Discover TRI's
History
Mission
Vision
Values
Our mission, vision, and values are unified in a single goal, to simplify Risk-Based Quality Management (RBQM) for all clinical trials.
HISTORY
About TRI
Take a moment to explore TRI's history through our significant milestones. Since our establishment in 2013, we have been at the forefront of providing exceptional quality management solutions.
2013
Establishing our foundation in Cambridge, UK
In 2013, TRI marked its entry into the world of clinical trial quality management by opening our first office in the historic and intellectually vibrant city of Cambridge. This milestone symbolized our commitment to innovation and excellence, setting the stage for a future where research and technology converge to redefine industry standards.
2016
Introducing OPRA, a new era of monitoring
Our journey took a significant leap forward in 2016 with the launch of OPRA-CM, our centralized monitoring platform. Designed with precision and user experience in mind, OPRA-CM revolutionized how research data is monitored, ensuring higher quality, efficiency, and compliance in clinical trials. This innovation underscored our dedication to transforming research methodologies through smart technology.
2020
Further advancing risk management
In 2020, TRI once again pushed the boundaries of quality management by unveiling our advanced risk assessment and management tool, OPRA-RAM. This tool was developed to empower researchers to proactively identify, evaluate, and mitigate risks in their studies, ensuring the utmost integrity and reliability of research outcomes. This launch not only highlighted our ongoing commitment to safety and excellence but also set new benchmarks in research risk management.
MISSION
To make RBQM simple for all clinical trials
At TRI, our mission is to make Risk-Based Quality Management simple; making it accessible, understandable, and actionable for clinical trials of any scale and complexity. We develop innovative technologies and simplified solutions to empower research organizations and sponsors, ensuring the highest standards of trial integrity and participant safety.
VISION
Enhanced efficiency and patient safety for all trials
Our vision is to be the global catalyst for change in clinical research, where RBQM is not a regulatory burden, but a standard practice embraced for its simplicity and effectiveness. We envision a future where every clinical trial, regardless of size or scope, benefits from advanced, intuitive RBQM solutions, driving efficiencies, enhancing safety, and ultimately accelerating the delivery of life-saving treatments to those in need.
VALUES
Our core values are at the heart of our mission
Our values are the foundation of our mission to simplify RBQM for clinical trials. Listed below, these principles guide our every decision, ensuring we deliver solutions that make a meaningful difference in the world of clinical research.
We are committed to simplifying complex processes, eliminating obstacles to the adoption and implementation of Risk-Based Quality Management (RBQM) for all clinical trials.
We are committed to continuous improvement and innovation, ensuring our solutions remain at the forefront of technology and best practice in clinical trial quality management.
We uphold the highest standards of ethical conduct and transparency in all our operations, ensuring trust and reliability in our solutions and partnerships.
Our strength lies in our unity. We actively support one another, both within and across departments, embracing a spirit of collaboration and mutual aid. By pooling our talents and resources, we overcome challenges, innovate solutions, and achieve collective goals, strengthening our organization.
OUR TEAM
Meet the team
With a passion for innovation and a dedication to excellence, our team brings diverse expertise to every project.
TESTIMONIALS
RBQM Success Stories
Hear directly from our partners about how we've helped them.
What truly set TriTrials apart from other vendors was their unparalleled commitment to a quality deliverable helping us effectively apply a novel approach to our operations. They achieved a deep understanding of our objectives by partnering with us on a rigorous change management process which culminated in a shared vision for the integration of their risk assessment and central monitoring solution.
The Worldwide Clinical Trials team is pleased with our continued partnership with TRI and we are excited about the milestone of having 150 clinical trials in TRI's Risk-Based Quality Management platform. This is a key benefit for our customers as it improves data quality, trial efficiency, and patient safety.
RBQM NEWS
Clinical trial quality news and views
Subscribe to get the latest RBQM insights sent to your mailbox.
Risk-Based Clinical Data Management Takes Center Stage at SCDM 2024
The Society for Clinical Data Management (SCDM) annual conference has always been a cornerstone for clinical data professionals, but this year’s event, held in Boston from September 30th to October…
The Quality Issue – September 2024
Welcome to this month’s Quality Issue, where we spotlight some of the most important developments in clinical research and Risk-Based Quality Management (RBQM). From transformative FDA guidance to our upcoming…
Inside the FDA’s Radical New Plan to Revolutionize Drug Development
The FDA has just released a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice Guidance for Industry” aimed at transforming how Randomized Controlled…